ALLIANCE-A082304-PROSPECT-LUNG
Phase III
OPEN TO ACCRUAL
Perioperative Versus Adjuvant Systemic Therapy in Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG
AZ-D516NC00001-TROPION-LUNG14
Phase III
OPEN TO ACCRUAL *
A Phase III, Open-Label, Randomised Study of Osimertinib with or without Datopotamab Deruxtecan (Dato-DXd), as First-Line Treatment in Participants with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
IIT-THOMPSON-RADIANCE-LUNG-X
Phase II
OPEN TO ACCRUAL
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-Small Cell Lung Cancers (RadiaNCe Lung X)
MIRATI-1719-001
Phase I/II
OPEN TO ACCRUAL
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1719 in Patients with Advanced Solid Tumors with Homozygous MTAP Deletion
NRG-LU008
Phase III
OPEN TO ACCRUAL
Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
VOLASTRA-VLS-1488-2201
Phase I/II
OPEN TO ACCRUAL
A Phase I/II Study of VLS-1488 (an Oral KIF18A Inhibitor) in Subjects with Advanced Cancer